A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

The increasing knowledge on inflammatory pathways has driven the development of targeted biological therapies for severe refractory asthma. Among the recently developed biologics, the fully human monoclonal antibody dupilumab is an interesting therapeutic option, given its ability to inhibit the bio...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ther Clin Risk Manag
Prif Awduron: Menzella, Francesco, Montanari, Gloria, Patricelli, Giulia, Cavazza, Alberto, Galeone, Carla, Ruggiero, Patrizia, Bagnasco, Diego, Facciolongo, Nicola
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove 2019
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636310/
https://ncbi.nlm.nih.gov/pubmed/31371974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S207402
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg